WHO ICTRP trial
Clinical trial with Transidose (=Lactulose) for oral intake regarding efficacy…
EUCTR2013-002900-15-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-002900-15-DE |
|---|---|
| Public title | Clinical trial with Transidose (=Lactulose) for oral intake regarding efficacy and safety in patients suffering from constipation. |
| Scientific title | Clinical trial to evaluate the efficacy and safety of oral Transidose in patients suffering from constipation. |
| Primary sponsor | Salsarulo Pharma |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Constipation MedDRA version: 18.1 Level: PT Classification code 10010774 Term: Constipation System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Transidose Product Code: Transidose Pharmaceutical Form: Oral paste INN or Proposed INN: LACTULOSE CAS Number: 4618-18-2 Concentration unit: g gram(s) Concentration type: equal Concentration number: 3.5- |
| Registration date | Apr 3, 2014 |
| Secondary IDs | Transidose-GE_01/2013 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: